Royalty Pharma maintains the highest standards of integrity and trust. This is recognized in our market-leading position and the high esteem with which we are held in the industry. We conduct thorough due diligence and monitoring with all our investment positions. Pharmaceutical companies typically have well-developed and transparent governance policies which seek to benefit wider society through sustainable and ethical business practices, as do the academic and non-profit institutions with which we work.
We have a robust set of IT/cybersecurity policies and compliance framework which includes policies related to EEO, anti-bribery, whistleblower hotline, FCPA, insider trading, and anti-fraud, document retention, to name a few. We consider social responsibility as one of the five categories of major proxy-related issues.